Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
Clinical trial NCT02142725 · TERMINATED
Trial details
- NCT number
- NCT02142725
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-21
- Primary completion
- 2016-11-11
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.